help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on September 5, 2008, doi:10.1164/rccm.200708-1219OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200708-1219OCv1
178/10/1055    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacLean, J. E.
Right arrow Articles by Subbarao, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacLean, J. E.
Right arrow Articles by Subbarao, P.
American Journal of Respiratory and Critical Care Medicine Vol 178. pp. 1055-1059, (2008)
© 2008 American Thoracic Society
doi: 10.1164/rccm.200708-1219OC


Original Article

Longitudinal Decline in Lung Volume in a Population of Children with Sickle Cell Disease

Joanna E. MacLean1, Eshetu Atenafu2, Melanie Kirby-Allen3, Ian B. MacLusky1, Derek Stephens2, Hartmut Grasemann1 and Padmaja Subbarao1

1 Division of Respiratory Medicine, 2 Child Health Evaluative Sciences, Research Institute, 3 Division of Hematology/Oncology, Department of Pediatrics, the Hospital for Sick Children and the University of Toronto, Toronto, Ontario, Canada

Correspondence and requests for reprint should be addressed to Joanna E. MacLean, M.D., F.A.A.P., F.R.C.P (C), Department of Respiratory Medicine, Children's Hospital at Westmead, Locked Bag 4001, Westmead, New South Wales 2145, Australia. E-mail: joannam4{at}med.usyd.edu.au

Rationale: Sickle cell disease (SCD) results in significant morbidity and mortality attributable to pulmonary complications. The pattern of lung function change across childhood in SCD is not well delineated.

Objectives: To determine if the pattern of lung function in SCD differs from race-matched, predicted values across childhood, to describe that pattern of change, and to examine the effect of clinical covariates on lung function.

Methods: Lung function measurements for children with SCD, aged 8–18 years, from a single center were examined for inclusion. Mixed-model analysis was used to retrospectively review lung function in these children in comparison with those predicted by race-matched reference equations. The contribution of age, sex, Hb level, and β-globin genotype on longitudinal changes in lung function was examined.

Measurements and Main Results: Children with SCD show significant decline in spirometric lung volumes across childhood that are concordant with the pattern of change in other measures of lung volume. The average decline for FEV1 and total lung capacity is 2.93 and 2.15% predicted/year for males and 2.95 and 2.43% predicted/year for females. β-Globin genotypes known to be associated with more severe disease showed a faster decline in lung function, whereas sex showed an inconsistent effect on lung function.

Conclusions: Lung volumes in children with SCD decline with age. The pattern of decline begins in childhood, and supports a predominately restrictive defect.

Key Words: spirometry • lung volume • genotype • race matched


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Sickle cell disease (SCD) is a common genetic disease with significant morbidity and mortality due to progressive lung disease. Although patients with SCD have been reported to have both obstructive and restrictive changes, changes in the pattern of lung function over time from childhood are not well delineated.

What This Study Adds to the Field
Lung volume, as a percentage of that predicted, declines with age in children with SCD; this decline begins in childhood. The rate of decline is similar to that of children with cystic fibrosis and greater than that of children with asthma.

 



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
A. C. Koumbourlis, D. J. Lee, and A. Lee
Changes in Lung Function in Children with Sickle Cell Disease
Am. J. Respir. Crit. Care Med., August 15, 2009; 180(4): 377 - 377.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. E. MacLean, H. Grasemann, and P. Subbarao
Changes in Lung Function in Children with Sickle Cell Disease
Am. J. Respir. Crit. Care Med., August 15, 2009; 180(4): 377 - 378.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Bush
Update in Pediatric Lung Disease 2008
Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 637 - 649.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2008 American Thoracic Society
  Membership Renewal